Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Shan, Jianqin
73  Ergebnisse:
Personensuche X
?
1

A Prognostic Model of Therapy-Related Myelodysplastic Syndr..:

Quintás-Cardama, Alfonso ; Daver, Naval ; Kim, Hawk...
Clinical Lymphoma Myeloma and Leukemia.  14 (2014)  5 - p. 401-410 , 2014
Link: https://doi.org/10.1016/..
 
?
2

Predicting survival of patients with hypocellular myelodysp..:

Tong, Wei‐Gang ; Quintás‐Cardama, Alfonso ; Kadia, Tapan...
Cancer.  118 (2012)  18 - p. 4462-4470 , 2012
Link: https://doi.org/10.1002/..
 
?
3

Very long‐term follow‐up results of imatinib mesylate thera..:

Kantarjian, Hagop ; O'Brien, Susan ; Garcia‐Manero, Guillermo...
Cancer.  118 (2012)  12 - p. 3116-3122 , 2012
Link: https://doi.org/10.1002/..
 
?
4

Clofarabine with high dose cytarabine and granulocyte colon..:

Becker, Pamela S. ; Kantarjian, Hagop M. ; Appelbaum, Frederick R....
British Journal of Haematology.  155 (2011)  2 - p. 182-189 , 2011
Link: https://doi.org/10.1111/..
 
?
5

Prediction model for mortality after intracranial hemorrhag..:

Dayyani, Farshid ; Mougalian, Sarah Schellhorn ; Naqvi, Kiran...
American Journal of Hematology.  86 (2011)  7 - p. 546-549 , 2011
Link: https://doi.org/10.1002/..
 
?
6

Prognostic impact of deletions of derivative chromosome 9 i..:

Quintás‐Cardama, Alfonso ; Kantarjian, Hagop ; Shan, Jianqin...
Cancer.  117 (2011)  22 - p. 5085-5093 , 2011
Link: https://doi.org/10.1002/..
 
?
7

Significance of Thrombocytopenia in Myelodysplastic Syndrom..:

Al Ameri, Ali ; Jabbour, Elias ; Garcia-Manero, Guillermo...
Clinical Lymphoma Myeloma and Leukemia.  11 (2011)  2 - p. 237-241 , 2011
Link: https://doi.org/10.1016/..
 
?
8

Current event‐free survival after sequential tyrosine kinas..:

Al‐Kali, Aref ; Kantarjian, Hagop ; Shan, Jianqin...
Cancer.  117 (2010)  2 - p. 327-335 , 2010
Link: https://doi.org/10.1002/..
 
?
9

Imatinib front-line therapy is safe and effective in patien..:

Tong, Wei-Gang ; Kantarjian, Hagop ; O'Brien, Susan...
Cancer.  116 (2010)  13 - p. 3152-3159 , 2010
Link: https://doi.org/10.1002/..
 
?
10

Survival outcomes for clonal evolution in chronic myeloid l..:

Verma, Dushyant ; Kantarjian, Hagop ; Shan, Jianqin...
Cancer.  116 (2010)  11 - p. 2673-2681 , 2010
Link: https://doi.org/10.1002/..
 
?
11

Significance of suboptimal response to imatinib, as defined..:

Alvarado, Yesid ; Kantarjian, Hagop ; O'Brien, Susan...
Cancer.  115 (2009)  16 - p. 3709-3718 , 2009
Link: https://doi.org/10.1002/..
 
?
12

Superior outcome with hypomethylating therapy in patients w..:

Ravandi, Farhad ; Issa, Jean‐Pierre ; Garcia‐Manero, Guillermo...
Cancer.  115 (2009)  24 - p. 5746-5751 , 2009
Link: https://doi.org/10.1002/..
 
?
13

The heterogeneous prognosis of patients with myelodysplasti..:

Kantarjian, Hagop ; O'Brien, Susan ; Ravandi, Farhad...
Cancer.  115 (2009)  22 - p. 5202-5209 , 2009
Link: https://doi.org/10.1002/..
 
?
14

Proposal for a new risk model in myelodysplastic syndrome t..:

Kantarjian, Hagop ; O'Brien, Susan ; Ravandi, Farhad...
Cancer.  113 (2008)  6 - p. 1351-1361 , 2008
Link: https://doi.org/10.1002/..
 
?
15

Cytogenetic and molecular responses and outcome in chronic ..:

Kantarjian, Hagop ; O'Brien, Susan ; Shan, Jianqin...
Cancer.  112 (2008)  4 - p. 837-845 , 2008
Link: https://doi.org/10.1002/..
 
1-15